Lymphoproliferative Disorders

"Lymphoproliferative Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Disorders characterized by proliferation of lymphoid tissue, general or unspecified.

Descriptor ID	D008232
MeSH Number(s)	C15.604.515 C20.683.515
Concept/Terms	Lymphoproliferative Disorders Lymphoproliferative Disorders Disorder, Lymphoproliferative Disorders, Lymphoproliferative Lymphoproliferative Disorder X-Linked Lymphoproliferative Disorder X-Linked Lymphoproliferative Disorder Disorder, X-Linked Lymphoproliferative Disorders, X-Linked Lymphoproliferative Lymphoproliferative Disorder, X-Linked Lymphoproliferative Disorders, X-Linked X Linked Lymphoproliferative Disorder X-Linked Lymphoproliferative Disorders Epstein-Barr Virus Infection, Familial Fatal Epstein Barr Virus Infection, Familial Fatal Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males Epstein Barr Virus Induced Lymphoproliferative Disease In Males Familial Fatal Epstein-Barr Infection Familial Fatal Epstein Barr Infection Immunodeficiency 5 Immunodeficiency 5s Duncan's Syndrome Lymphoproliferative Disease, X-Linked Disease, X-Linked Lymphoproliferative Diseases, X-Linked Lymphoproliferative Lymphoproliferative Disease, X Linked Lymphoproliferative Diseases, X-Linked X-Linked Lymphoproliferative Diseases Lymphoproliferative Syndrome, X-Linked, 1 Purtilo Syndrome Purtilo Syndromes Syndrome, Purtilo Syndromes, Purtilo X-Linked Lymphoproliferative Disease X Linked Lymphoproliferative Disease X-Linked Lymphoproliferative Syndrome Lymphoproliferative Syndrome, X-Linked Lymphoproliferative Syndromes, X-Linked Syndrome, X-Linked Lymphoproliferative Syndromes, X-Linked Lymphoproliferative X Linked Lymphoproliferative Syndrome X-Linked Lymphoproliferative Syndromes Duncan Disease Disease, Duncan Immunodeficiency, X-Linked Progressive Combined Variable Immunodeficiency, X Linked Progressive Combined Variable

Below are MeSH descriptors whose meaning is more general than "Lymphoproliferative Disorders".

Diseases [C]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]

Below are MeSH descriptors whose meaning is related to "Lymphoproliferative Disorders".

Below are MeSH descriptors whose meaning is more specific than "Lymphoproliferative Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lymphoproliferative Disorders" by people in this website by year, and whether "Lymphoproliferative Disorders" was a major or minor topic of these publications.

Bar chart showing 11 publications over 10 distinct years, with a maximum of 2 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	0	1	1
2004	1	0	1
2006	2	0	2
2012	1	0	1
2015	1	0	1
2018	1	0	1
2020	1	0	1
2022	1	0	1
2023	1	0	1
2024	0	1	1

Below are the most recent publications written about "Lymphoproliferative Disorders" by people in Profiles.

Sullivan KE, Lambert M. Ras-associated autoimmune lymphoproliferative disorder. Br J Haematol. 2024 Sep; 205(3):819-822.

View in: PubMed
Chen JH, Arceri T, Datta R, Sullivan KE. Delayed post-COVID-19 hemophagocytic lymphohistiocytosis in patient with XIAP deficiency. Pediatr Allergy Immunol. 2023 09; 34(9):e14028.

View in: PubMed
D?vila Salda?a BJ, John T, Bonifant C, Buchbinder D, Chandra S, Chandrakasan S, Chang W, Chen L, Elfassy HL, Geerlinks AV, Giller RH, Goyal R, Hagin D, Islam S, Mallhi K, Miller HK, Owen W, Pacheco M, Patel NC, Querfeld C, Quigg T, Richard N, Schiff D, Shereck E, Stenger E, Jordan MB, Heslop HE, Bollard CM, Cohen JI. High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia. Blood Adv. 2022 01 25; 6(2):452-459.

View in: PubMed
Yakaboski E, Fuleihan RL, Sullivan KE, Cunningham-Rundles C, Feuille E. Lymphoproliferative Disease in CVID: a Report of Types and Frequencies from a US Patient Registry. J Clin Immunol. 2020 04; 40(3):524-530.

View in: PubMed
Piccolo V, Russo T, Agozzino M, Vitiello P, Caccavale S, Alfano R, Argenziano G. Dermoscopy of Cutaneous Lymphoproliferative Disorders: Where Are We Now? Dermatology. 2018; 234(3-4):131-136.

View in: PubMed
Kelsen JR, Dawany N, Martinez A, Martinez A, Grochowski CM, Maurer K, Rappaport E, Piccoli DA, Baldassano RN, Mamula P, Sullivan KE, Devoto M. A de novo whole gene deletion of XIAP detected by exome sequencing analysis in very early onset inflammatory bowel disease: a case report. BMC Gastroenterol. 2015 Nov 18; 15:160.

View in: PubMed
Noh TK, Haw S, Soung JH, Won CH, Chang S, Choi JH, Moon KC, Park YS, Lee MW. Systemic lupus erythematous presenting with hydroa vacciniforme-like eruption: mimicking Epstein-Barr virus-associated lymphoproliferative disorders. J Dermatol. 2012 Dec; 39(12):1095-7.

View in: PubMed
Teachey DT, Obzut DA, Axsom K, Choi JK, Goldsmith KC, Hall J, Hulitt J, Manno CS, Maris JM, Rhodin N, Sullivan KE, Brown VI, Grupp SA. Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS). Blood. 2006 Sep 15; 108(6):1965-71.

View in: PubMed
Filipovich A, Conley ME, Nichols KE, Sullivan KE. X-linked lymphoproliferative syndrome: an X-cellent question. Clin Immunol. 2006 Jun; 119(3):241-4.

View in: PubMed
Teachey DT, Manno CS, Axsom KM, Andrews T, Choi JK, Greenbaum BH, McMann JM, Sullivan KE, Travis SF, Grupp SA. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood. 2005 Mar 15; 105(6):2443-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals